4basebio (XTER:88Q) Additional Paid-In Capital : €0.82 Mil(As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio Additional Paid-In Capital?

4basebio's quarterly additional paid-in capital declined from Jun. 2022 (€0.82 Mil) to Dec. 2022 (€0.81 Mil) but then increased from Dec. 2022 (€0.81 Mil) to Jun. 2023 (€0.82 Mil).

4basebio's annual additional paid-in capital increased from Dec. 2020 (€0.78 Mil) to Dec. 2021 (€0.83 Mil) but then declined from Dec. 2021 (€0.83 Mil) to Dec. 2022 (€0.81 Mil).

4basebio Additional Paid-In Capital Historical Data

The historical data trend for 4basebio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Additional Paid-In Capital Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

0.78

0.83

0.81

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial			0.82	0.83	0.82	0.81	0.82

4basebio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

4basebio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of 4basebio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (XTER:88Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

4BB:UK

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines